相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective
Yu-Chi Chen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)
Immunogenic cell stress and death
Guido Kroemer et al.
NATURE IMMUNOLOGY (2022)
Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity
Yan Wang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Interim Results from the First Clinical Study of CC-95251, an Anti-Signal Regulatory Protein-Alpha (SIRPα) Antibody, in Combination with Rituximab in Patients with Relapsed and/or Refractory Non-Hodgkin Lymphoma (R/R NHL)
Paolo Strati et al.
BLOOD (2021)
The SIRPα-CD47 immune checkpoint in NK cells
Tobias Deuse et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Novel SIRPα Antibodies That Induce Single-Agent Phagocytosis of Tumor Cells while Preserving T Cells
Gabriela Andrejeva et al.
JOURNAL OF IMMUNOLOGY (2021)
Engineering precision nanoparticles for drug delivery
Michael J. Mitchell et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
SIRPα Suppresses Response to Therapeutic Antibodies by Nurse Like Cells From Chronic Lymphocytic Leukemia Patients
Yu-Chen Enya Chen et al.
FRONTIERS IN IMMUNOLOGY (2021)
Ultrasound-targeted nucleic acid delivery for solid tumor therapy
Mark R. Schwartz et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer
Runzhe Shu et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Expression and Prognostic Significance of CD47-SIRPA Macrophage Checkpoint Molecules in Colorectal Cancer
Akane Sugimura-Nagata et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Combinatory Delivery of Etoposide and siCD47 in a Lipid Polymer Hybrid Delays Lung Tumor Growth in an Experimental Melanoma Lung Metastatic Model
Hend Mohamed Abdel-Bar et al.
ADVANCED HEALTHCARE MATERIALS (2021)
An antitumor peptide RS17-targeted CD47, design, synthesis, and antitumor activity
Xinmin Wang et al.
CANCER MEDICINE (2021)
The Current Status of MOF and COF Applications
Ralph Freund et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
CD47-targeted cancer immunogene therapy : Secreted SIRPa-Fc fusion protein eradicates tumors by macrophage and NK cell activation
Magdalena Billerhart et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
ALTA-002, A SIRPα-DIRECTED TLR9 AGONIST ANTIBODY CONJUGATE ACTIVATES MYELOID CELLS AND PROMOTES ANTI-TUMOR IMMUNITY
Ons Harrabi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
CD47-mediated DTIC-loaded chitosan oligosaccharide-grafted nGO for synergistic chemo-photothermal therapy against malignant melanoma
Xiaozhen Zhan et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)
Innate Immune Checkpoint Inhibitors: The Next Breakthrough in Medical Oncology?
Robert W. Lentz et al.
MOLECULAR CANCER THERAPEUTICS (2021)
The evolution of commercial drug delivery technologies
Ava M. Vargason et al.
NATURE BIOMEDICAL ENGINEERING (2021)
Gene-engineered exosomes-thermosensitive liposomes hybrid nanovesicles by the blockade of CD47 signal for combined photothermal therapy and cancer immunotherapy
Lili Cheng et al.
BIOMATERIALS (2021)
Discovery of RRx-001, a Myc and CD47 Downregulating Small Molecule with Tumor Targeted Cytotoxicity and Healthy Tissue Cytoprotective Properties in Clinical Development
Bryan Oronsky et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
The regulation of CD47-SIRPα signaling axis by microRNAs in combination with conventional cytotoxic drugs together with the help of nano-delivery: a choice for therapy?
Zahra Beizavi et al.
MOLECULAR BIOLOGY REPORTS (2021)
Detachable Liposomes Combined Immunochemotherapy for Enhanced Triple-Negative Breast Cancer Treatment through Reprogramming of Tumor-Associated Macrophages
Mingshu Chen et al.
NANO LETTERS (2021)
Extracellular vesicles as a next-generation drug delivery platform
Inge Katrin Herrmann et al.
NATURE NANOTECHNOLOGY (2021)
Luteolin promotes macrophage-mediated phagocytosis by inhibiting CD47 pyroglutamation
Zhiqiang Li et al.
TRANSLATIONAL ONCOLOGY (2021)
Time-Programmed Delivery of Sorafenib and Anti-CD47 Antibody via a Double-Layer-Gel Matrix for Postsurgical Treatment of Breast Cancer
Liping Huang et al.
NANO-MICRO LETTERS (2021)
Third-Generation Anti-CD47-Specific CAR-T Cells Effectively Kill Cancer Cells and Reduce the Genes Expression in Lung Cancer Cell Metastasis
Huyen Thi La et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2021)
Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead
Kedar Kirtane et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Anti-CD47 Monoclonal Antibody-Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers
Yingnan Si et al.
VACCINES (2021)
Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy
Jianbing Du et al.
THERANOSTICS (2021)
Improvement of the pharmacokinetic characteristics of liposomal doxorubicin using CD47 biomimickry
Seyed Mohammad Gheibihayat et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2021)
The development of small-molecule inhibitors targeting CD47
Wei-Bang Yu et al.
DRUG DISCOVERY TODAY (2021)
Sendai virus acts as a nano-booster to excite dendritic cells for enhancing the efficacy of CD47-directed immune checkpoint inhibitors against breast carcinoma
Yanan Xu et al.
MATERIALS CHEMISTRY FRONTIERS (2021)
Recent advances and discoveries in the mechanisms and functions of CAR T cells
Rebecca C. Larson et al.
NATURE REVIEWS CANCER (2021)
Macrophage-Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention
Xuefei Zhou et al.
ADVANCED FUNCTIONAL MATERIALS (2021)
Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications
Yi Wang et al.
THERANOSTICS (2021)
Considerations for the Design of Antibody-Based Therapeutics
Dennis R. Goulet et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-Target Effects with Reduced Off-Tumor Toxicity for Use in Immuno-Oncology
Karen A. Autio et al.
CLINICAL CANCER RESEARCH (2020)
Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma
Nasrin Rastgoo et al.
HAEMATOLOGICA (2020)
Responsive Exosome Nano-bioconjugates for Synergistic Cancer Therapy
Weidong Nie et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
A synergistic cancer immunotherapy nano-system for preventing tumor growth
Yingying Zhang et al.
CHEMICAL ENGINEERING JOURNAL (2020)
Magnetic, fluorescent and hybrid nanoparticles: From synthesis to application in biosystems
Goncalo A. Marcelo et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2020)
Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell Binding
Robyn J. Puro et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Targeting Tumor Microenvironment by Small-Molecule Inhibitors
Shangwei Zhong et al.
TRANSLATIONAL ONCOLOGY (2020)
Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma
Jennifer Sun et al.
CANCERS (2020)
MicroRNA-200a Promotes Phagocytosis of Macrophages and Suppresses Cell Proliferation, Migration, and Invasion in Nasopharyngeal Carcinoma by Targeting CD47
Yunteng Zhao et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potential
Linlin Ma et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
Rationale and necessity for delivery of RRx-001, a Myc and CD47 antagonist, by intravenous blood mix
Scott Caroen et al.
EXPERT OPINION ON DRUG DELIVERY (2020)
Phagocytosis: Our Current Understanding of a Universal Biological Process
Eileen Uribe-Querol et al.
FRONTIERS IN IMMUNOLOGY (2020)
miR-128 Regulates Tumor Cell CD47 Expression and Promotes Anti-tumor Immunity in Pancreatic Cancer
Qing Xi et al.
FRONTIERS IN IMMUNOLOGY (2020)
CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis
Meghan A. Morrissey et al.
IMMUNITY (2020)
Restoration of miR-340 controls pancreatic cancer cellCD47expression to promote macrophage phagocytosis and enhance antitumor immunity
Qing Xi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer
Yun Liu et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Role of CD47 in Hematological Malignancies
Entsar Eladl et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Activating Macrophage-Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles
Lang Rao et al.
ADVANCED MATERIALS (2020)
Nanoscale Metal-Organic Framework Co-delivers TLR-7 Agonists and Anti-CD47 Antibodies to Modulate Macrophages and Orchestrate Cancer Immunotherapy
Kaiyuan Ni et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
The tumor microenvironment
Nicole M. Anderson et al.
CURRENT BIOLOGY (2020)
Utilization of Polymer-Lipid Hybrid Nanoparticles for Targeted Anti-Cancer Therapy
Ayeskanta Mohanty et al.
MOLECULES (2020)
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis
Lang Rao et al.
NATURE COMMUNICATIONS (2020)
CD47/SIRP alpha blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy
Hongfei Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
CD47 Enhances Cell Viability and Migration Ability but Inhibits Apoptosis in Endometrial Carcinoma Cells via the PI3K/Akt/mTOR Signaling Pathway
Yun Liu et al.
FRONTIERS IN ONCOLOGY (2020)
NOVEL ANTI-SIRPALPHA ANTIBODIES WITH DIFFERENTIATED CHARACTERISTICS AS PROMISING CANCER THERAPEUTICS
Minu K. Srivastava et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Multivalent, Soluble Nano-Self Peptides Increase Phagocytosis of Antibody-Opsonized Targets while Suppressing Self Signaling
AbdelAziz R. Jalil et al.
ACS NANO (2020)
Nanoparticle-Enabled Dual Modulation of Phagocytic Signals to Improve Macrophage-Mediated Cancer Immunotherapy
Ya-Ru Zhang et al.
SMALL (2020)
Macrocyclic Peptide-Mediated Blockade of the CD47-SIRPα Interaction as a Potential Cancer Immunotherapy
Daisuke Hazama et al.
CELL CHEMICAL BIOLOGY (2020)
Tumor-intrinsic CD47 signal regulates glycolysis and promotes colorectal cancer cell growth and metastasis
Tuo Hu et al.
THERANOSTICS (2020)
Lipid-based phagocytosis nanoenhancer for macrophage immunotherapy
Anujan Ramesh et al.
NANOSCALE (2020)
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer
Alison K. Esser et al.
THERANOSTICS (2020)
CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer
Bernhard Kiss et al.
CLINICAL CANCER RESEARCH (2019)
Characterization of a Novel Third-Generation Anti-CD24-CAR against Ovarian Cancer
Ruediger Klapdor et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Glutaminyl cyclase is an enzymatic modifier of the CD47-SIRPα axis and a target for cancer immunotherapy
Meike E. W. Logtenberg et al.
NATURE MEDICINE (2019)
Cell membrane-covered nanoparticles as biomaterials
Mingjun Xuan et al.
NATIONAL SCIENCE REVIEW (2019)
RRX-001 Acts as a dual small Molecule Checkpoint Inhibitor by Downregulating CD47 on Cancer Cells and SIRP-α on Monocytes/Macrophages
Pedro Cabrales
TRANSLATIONAL ONCOLOGY (2019)
Metformin mediates induction of miR-708 to inhibit self-renewal and chemoresistance of breast cancer stem cells through targeting CD47
Weige Tan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Characterization of the Pathophysiological Role of CD47 in Uveal Melanoma
Maria Cristina Petralia et al.
MOLECULES (2019)
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Amira A. Barkal et al.
NATURE (2019)
Programmable bacteria as cancer therapy
Michael Dougan et al.
NATURE MEDICINE (2019)
Programmable bacteria induce durable tumor regression and systemic antitumor immunity
Sreyan Chowdhury et al.
NATURE MEDICINE (2019)
Combined high expression of CD47 and CD68 is a novel prognostic factor for breast cancer patients
Jingping Yuan et al.
CANCER CELL INTERNATIONAL (2019)
CSF1R-and SHP2-Inhibitor-Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor-Associated Macrophages
Anujan Ramesh et al.
ADVANCED MATERIALS (2019)
CD47 promotes cell growth and motility in epithelial ovarian cancer
Chiu-Lin Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
TJC4, a Differentiated Anti-CD47 Antibody with Novel Epitope and RBC Sparing Properties
Zhen Meng et al.
BLOOD (2019)
A Phase 1 Study Evaluating BI 765063, a First in Class Selective Myeloid Sirpa Inhibitor, As Stand-Alone and in Combination with BI 754091, a Programmed Death-1 (PD-1) Inhibitor, in Patients with Advanced Solid Tumours
Jean-Pierre Delord et al.
BLOOD (2019)
The First-in-Class Anti-CD47 Antibody Magrolimab (5F9) in Combination with Azacitidine Is Effective in MDS and AML Patients: Ongoing Phase 1b Results
David A. Sallman et al.
BLOOD (2019)
CD47-targeted bismuth selenide nanoparticles actualize improved photothermal therapy by increasing macrophage phagocytosis of cancer cells
Zhaoming Guo et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Xianjie Jiang et al.
MOLECULAR CANCER (2019)
Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated 'don't-eat-me' signal
Mingen Liu et al.
NATURE IMMUNOLOGY (2019)
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
Qian Chen et al.
NATURE NANOTECHNOLOGY (2019)
Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα-CD47 innate immune checkpoint
Erik Voets et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Phagocytosis checkpoints as new targets for cancer immunotherapy
Mingye Feng et al.
NATURE REVIEWS CANCER (2019)
On the role of helper lipids in lipid nanoparticle formulations of siRNA
Jayesh A. Kulkarni et al.
NANOSCALE (2019)
Cell Membrane Coating Nanotechnology
Ronnie H. Fang et al.
ADVANCED MATERIALS (2018)
pH protective Y1 receptor ligand functionalized antiphagocytosis BPLP-WPU micelles for enhanced tumor imaging and therapy with prolonged survival time
Zhenqi Jiang et al.
BIOMATERIALS (2018)
Direct modulation of myelin-autoreactive CD4+ and CD8+ T cells in EAE mice by a tolerogenic nanoparticle co-carrying myelin peptide-loaded major histocompatibility complexes, CD47 and multiple regulatory molecules
Weiya Pei et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47
Wei Huang et al.
MOLECULAR CANCER (2018)
Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and Leukemia
Vanessa Buatois et al.
MOLECULAR CANCER THERAPEUTICS (2018)
A Glutamine-Rich Carrier Efficiently Delivers Anti-CD47 siRNA Driven by a Glutamine Trap To Inhibit Lung Cancer Cell Growth
Jiamin Wu et al.
MOLECULAR PHARMACEUTICS (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Quantum Dot-Dye Conjugates for Biosensing, Imaging, and Therapy
Sungwook Jung et al.
ADVANCED HEALTHCARE MATERIALS (2018)
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Flavia Castro et al.
FRONTIERS IN IMMUNOLOGY (2018)
Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma
Lei Wu et al.
ONCOIMMUNOLOGY (2018)
A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer
Ashish Kulkarni et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Surface-Enhanced Raman Scattering Nanoparticles for Multiplexed Imaging of Bladder Cancer Tissue Permeability and Molecular Phenotype
Ryan M. Davis et al.
ACS NANO (2018)
ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile
Steven E. Kauder et al.
PLOS ONE (2018)
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
A Raman Imaging Approach Using CD47 Antibody-Labeled SERS Nanoparticles for Identifying Breast Cancer and Its Potential to Guide Surgical Resection
Ryan M. Davis et al.
NANOMATERIALS (2018)
Therapeutic Potential of AO-176, a Next Generation Humanized CD47 Antibody, for Hematologic Malignancies
W. Casey Wilson et al.
BLOOD (2018)
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy
Amira A. Barkal et al.
NATURE IMMUNOLOGY (2018)
TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding
Penka S. Petrova et al.
CLINICAL CANCER RESEARCH (2017)
Liposome-based drug co-delivery systems in cancer cells
Sepideh Zununi Vahed et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2017)
Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies
Elie Dheilly et al.
MOLECULAR THERAPY (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Localized CD47 blockade enhances immunotherapy for murine melanoma
Jessica R. Ingram et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Stimuli-responsive liposomes for drug delivery
Y. Lee et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2017)
CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis
Ran Liu et al.
ONCOTARGET (2017)
In vivo biodistribution and toxicity of intravesical administration of quantum dots for optical molecular imaging of bladder cancer
Ying Pan et al.
SCIENTIFIC REPORTS (2017)
Immune-camouflaged graphene oxide nanosheets for negative regulation of phagocytosis by macrophages
G. Shim et al.
JOURNAL OF MATERIALS CHEMISTRY B (2017)
Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
Liang Liu et al.
FRONTIERS IN IMMUNOLOGY (2017)
CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth
Vita Golubovskaya et al.
CANCERS (2017)
Multifunctionalized iron oxide nanoparticles for selective targeting of pancreatic cancer cells
Sara Trabulo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis
Eunee Koh et al.
BIOMATERIALS (2017)
Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation
A. D. Garg et al.
CELL DEATH AND DIFFERENTIATION (2016)
Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications
Yongzhong Wang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Antibody-drug conjugates for cancer therapy
Anish Thomas et al.
LANCET ONCOLOGY (2016)
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis
Yoko Kojima et al.
NATURE (2016)
Durable antitumor responses to CD47 blockade require adaptive immune stimulation
Jonathan T. Sockolosky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
MYC regulates the antitumor immune response through CD47 and PD-L1
Stephanie C. Casey et al.
SCIENCE (2016)
A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer
Sukhbir Kaur et al.
ONCOTARGET (2016)
The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy
Jonathan T. Sockolosky et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
CD47 blockade triggers T cell-mediated destruction of immunogenic tumors
Xiaojuan Liu et al.
NATURE MEDICINE (2015)
miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47
Seung Yeob Yang et al.
Oncotarget (2015)
Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics
Timo Rath et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2015)
The Interaction Between Signal Regulatory Protein Alpha (SIRPα) and CD47: Structure, Function, and Therapeutic Target
A. Neil Barclay et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
EPR: Evidence and fallacy
Joseph W. Nichols et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Endoscopic molecular imaging of human bladder cancer using a CD47 antibody
Ying Pan et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
Wei Liao et al.
IMMUNITY (2013)
MicroRNA-17/20a/106a modulate macrophage inflammatory responses through targeting signal-regulatory protein alpha
Dihan Zhu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Intravenous Delivery of siRNA Targeting CD47 Effectively Inhibits Melanoma Tumor Growth and Lung Metastasis
Yuhua Wang et al.
MOLECULAR THERAPY (2013)
Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
Diane Tseng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Minimal Self Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Pia L. Rodriguez et al.
SCIENCE (2013)
Redirected T Cells That Target Pancreatic Adenocarcinoma Antigens Eliminate Tumors and Metastases in Mice
Amit Maliar et al.
GASTROENTEROLOGY (2012)
PLGA-based nanoparticles: An overview of biomedical applications
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2012)
CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma
Shigemasa Suzuki et al.
ONCOLOGY REPORTS (2012)
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Stephen B. Willingham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Therapeutic Antibody Targeting of CD47 Eliminates Human Acute Lymphoblastic Leukemia
Mark P. Chao et al.
CANCER RESEARCH (2011)
CD24 Offers a Therapeutic Target for Control of Bladder Cancer Metastasis Based on a Requirement for Lung Colonization
Jonathan B. Overdevest et al.
CANCER RESEARCH (2011)
Beginnings of a Good Apoptotic Meal: The Find-Me and Eat-Me Signaling Pathways
Kodi S. Ravichandran
IMMUNITY (2011)
Self inhibition of phagocytosis: The affinity of 'marker of self' CD47 for SIRPα dictates potency of inhibition but only at low expression levels
Richard K. Tsai et al.
BLOOD CELLS MOLECULES AND DISEASES (2010)
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
Mark P. Chao et al.
CELL (2010)
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Siddhartha Jaiswal et al.
CELL (2009)
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Ravindra Majeti et al.
CELL (2009)
Structure of Signal-regulatory Protein α A LINK TO ANTIGEN RECEPTOR EVOLUTION
Deborah Hatherley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Multiplexed imaging of surface enhanced Raman scattering nanotags in living mice using noninvasive Raman spectroscopy
Cristina L. Zavaleta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Functions and molecular mechanisms of the CD47-SIRPα signalling pathway
Takashi Matozaki et al.
TRENDS IN CELL BIOLOGY (2009)
Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA
Eyal Sagiv et al.
CANCER RESEARCH (2008)
Biological Research in the Evolution of Cancer Surgery: A Personal Perspective
Bernard Fisher
CANCER RESEARCH (2008)
Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47
Deborah Hatherley et al.
MOLECULAR CELL (2008)
Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells
Katsuto Takenaka et al.
NATURE IMMUNOLOGY (2007)
Reduced expression of CD47 during murine red blood cell (RBC) senescence and its role in RBC clearance from the circulation
Sanjay Khandelwal et al.
TRANSFUSION (2007)
Adhesion of human T cells to antigen-presenting cells through SIRPβ2-CD47 interaction costimulates T-cell proliferation
L Piccio et al.
BLOOD (2005)
Recent advances with liposomes as pharmaceutical carriers
VP Torchilin
NATURE REVIEWS DRUG DISCOVERY (2005)
Role of CD47 as a marker of self on red blood cells
PA Oldenborg et al.
SCIENCE (2000)
分享论文
